The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic Review
Jennifer Le Guévelou(Centre Eugène Marquis), Thomas Zilli(University of Geneva), Paul Sargos, Silke Gillessen(Institute of Oncology Research), Piet Ost(Ghent University Hospital), Shankar Siva(The University of Melbourne), Guillaume Ploussard(Yves Rocher (France))
Cited by 15
Related Papers
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
|Nature Medicine|2022|241
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
|European Urology|2019|191